1) agent organizational trust
Agent组织信任
1.
To this end,we propose a computational model of agent organizational trust CMAOT based on probability theory and computational model of trust in individual agent,taking account of frequency of interactions.
Agent信任研究已经成为多Agent系统理论研究的重要内容,但目前大多数研究都是关于个体Agent信任和声誉,较少涉及Agent组织信任研究;而且,开放网络环境中存在着的大量不精确和不完全信息,导致信任计算置信度不高。
2) organizational trust
组织信任
1.
An empirical study on interaction among organizational trust,knowledge sharing,and organizational performance;
组织信任、知识分享与组织绩效关系的实证研究
2.
The Relationships between Organizational Trust and Organizational Effectiveness of Private Enterprises;
民营企业组织信任与组织效能的相关研究
3.
A Study of Organizational Trust, Its Influence on Organizational Citizenship Behaviors and Turnover Intension and Its Relationship with Psychological Contract Breaches;
组织信任对组织公民行为、离职倾向的影响及其与心理契约违背的关系
3) organization trust
组织信任
1.
Discussion on Relationship of Organization Trust,Decision Commitment and Decision Quality;
组织信任及决策承诺与决策质量之关系探讨
2.
It is important and essential for a company to strength employees’ organization trust.
增强员工的组织信任对于企业组织来说,是十分重要且必须的。
4) agent trust
Agent信任
1.
In the research of multi-agent computing, there are four technologies that should be solved well: agent cooperation and coordination, agent communication, agent migration, agent trust and security.
在多Agent计算的研究中,有四种关键技术需要认真解决:Agent合作与协调,Agent通信,Agent迁移,Agent信任与安全。
2.
There have been a lot of researches on agent trust and reputation in the past few years,such as TRAVOS model presented by Teacy and FIRE model presented by Huynh.
然而目前agent信任研究都是以平均交互成功率来计算,较少考虑信任动态变化,因而准确预测和行为异常检测的能力不能令人满意。
5) trust in organization
组织内信任
1.
As the histology of modernistic enterprises take on the comolanate trend, trust in organization become more important.
现代企业组织呈现结构扁平化趋势,组织内信任显得更加重要。
6) inter-organizational trust
组织间信任
1.
Additionally, factors influencing inter-organizational trust are mutil-dimensional.
影响组织间信任的因素是多元和多层次的。
补充资料:[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式:C16H16ClN3O3S
分子量:365.5
CAS号:26807-65-8
性质:暂无
制备方法:暂无
用途:用于轻、中度原发性高血压。
分子量:365.5
CAS号:26807-65-8
性质:暂无
制备方法:暂无
用途:用于轻、中度原发性高血压。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条